相似文献
1
Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape.
Vaccine. 2013 Dec 5;31(50):5934-9. doi: 10.1016/j.vaccine.2013.10.044. Epub 2013 Oct 19.
2
Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains.
Emerg Infect Dis. 2009 Feb;15(2):335-9. doi: 10.3201/eid1502.080795.
3
Mycobacterium tuberculosis Beijing genotype emerging in Vietnam.
Emerg Infect Dis. 2000 May-Jun;6(3):302-5. doi: 10.3201/eid0603.000312.
4
The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Infect Immun. 2004 Nov;72(11):6622-32. doi: 10.1128/IAI.72.11.6622-6632.2004.
5
Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig.
Clin Vaccine Immunol. 2012 Aug;19(8):1227-37. doi: 10.1128/CVI.00250-12. Epub 2012 Jun 20.
6
Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype.
FEMS Immunol Med Microbiol. 2004 Nov 1;42(3):281-90. doi: 10.1016/j.femsim.2004.05.012.
7
Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
J Clin Microbiol. 2012 Sep;50(9):2857-62. doi: 10.1128/JCM.00358-12. Epub 2012 May 30.
8
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG.
Sci Rep. 2021 Jun 14;11(1):12417. doi: 10.1038/s41598-021-91993-8.
9
Genetic diversity and drug susceptibility of Mycobacterium tuberculosis isolates from Zunyi, one of the highest-incidence-rate areas in China.
J Clin Microbiol. 2012 Mar;50(3):1043-7. doi: 10.1128/JCM.06095-11. Epub 2012 Jan 11.
10
The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis.
PLoS One. 2015 Sep 14;10(9):e0136500. doi: 10.1371/journal.pone.0136500. eCollection 2015.
引用本文的文献
1
Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.
Tuberculosis (Edinb). 2018 Mar;109:123-133. doi: 10.1016/j.tube.2018.02.003. Epub 2018 Feb 9.
2
GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.
Clin Vaccine Immunol. 2017 Dec 5;24(12). doi: 10.1128/CVI.00245-17. Print 2017 Dec.
3
Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.
J Leukoc Biol. 2016 Apr;99(4):605-17. doi: 10.1189/jlb.4A0614-308RR. Epub 2015 Nov 20.
4
The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis.
PLoS One. 2015 Sep 14;10(9):e0136500. doi: 10.1371/journal.pone.0136500. eCollection 2015.
5
Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.
Tuberculosis (Edinb). 2014 Dec;94(6):606-15. doi: 10.1016/j.tube.2014.10.001.
本文引用的文献
1
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
Lancet. 2013 Mar 23;381(9871):1021-8. doi: 10.1016/S0140-6736(13)60177-4.
2
Prospects for tuberculosis elimination.
Annu Rev Public Health. 2013;34:271-86. doi: 10.1146/annurev-publhealth-031912-114431. Epub 2012 Dec 14.
3
Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig.
Clin Vaccine Immunol. 2012 Aug;19(8):1227-37. doi: 10.1128/CVI.00250-12. Epub 2012 Jun 20.
4
Vaccines against tuberculosis: where are we and where do we need to go?
PLoS Pathog. 2012;8(5):e1002607. doi: 10.1371/journal.ppat.1002607. Epub 2012 May 10.
5
The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Int J Tuberc Lung Dis. 2012 Jul;16(7):928-33. doi: 10.5588/ijtld.11.0679. Epub 2012 May 8.
6
Recombinant live vaccine candidates against tuberculosis.
Curr Opin Biotechnol. 2012 Dec;23(6):900-7. doi: 10.1016/j.copbio.2012.03.007. Epub 2012 Apr 4.
7
BCG: myths, realities, and the need for alternative vaccine strategies.
Tuberculosis (Edinb). 2012 May;92(3):283-8. doi: 10.1016/j.tube.2011.12.003. Epub 2012 Feb 18.
8
Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa.
Int J Tuberc Lung Dis. 2012 Feb;16(2):196-202. doi: 10.5588/ijtld.11.0116.
9
Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa.
Int J Tuberc Lung Dis. 2012 Jan;16(1):76-81. doi: 10.5588/ijtld.11.0360.
10
Tuberculosis vaccines: beyond bacille Calmette-Guerin.
Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2782-9. doi: 10.1098/rstb.2011.0097.
Zotero 插件